The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Perspective Therapeutics Inc’s stock clocked out at $3.82, down -7.06% from its previous closing price of $4.11. In other words, the price has decreased by -$7.06% from its previous closing price. On the day, 1.61 million shares were traded. CATX stock price reached its highest trading level at $4.44 during the session, while it also had its lowest trading level at $3.805.
Ratios:
To gain a deeper understanding of CATX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.02 and its Current Ratio is at 17.02. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $10.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.
BofA Securities Downgraded its Buy to Neutral on November 25, 2024, whereas the target price for the stock was revised from $24 to $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 28 ’25 when Spoor Johan M. bought 22,026 shares for $2.24 per share. The transaction valued at 49,384 led to the insider holds 59,383 shares of the business.
Spoor Johan M. bought 4,650 shares of CATX for $10,288 on Mar 28 ’25. The Chief Executive Officer now owns 4,650 shares after completing the transaction at $2.21 per share. On Mar 31 ’25, another insider, Williamson Robert F III, who serves as the Director of the company, bought 38,145 shares for $2.14 each. As a result, the insider paid 81,775 and bolstered with 108,982 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CATX now has a Market Capitalization of 283552128 and an Enterprise Value of 75668232. For the stock, the TTM Price-to-Sale (P/S) ratio is 192.89 while its Price-to-Book (P/B) ratio in mrq is 0.99. Its current Enterprise Value per Revenue stands at 51.44 whereas that against EBITDA is -1.037.
Stock Price History:
The Beta on a monthly basis for CATX is 1.15, which has changed by -0.59831756 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, CATX has reached a high of $16.55, while it has fallen to a 52-week low of $1.60. The 50-Day Moving Average of the stock is 42.53%, while the 200-Day Moving Average is calculated to be -30.65%.
Shares Statistics:
It appears that CATX traded 1.06M shares on average per day over the past three months and 1328990 shares per day over the past ten days. A total of 74.05M shares are outstanding, with a floating share count of 54.14M. Insiders hold about 27.07% of the company’s shares, while institutions hold 66.43% stake in the company. Shares short for CATX as of 1748563200 were 5278241 with a Short Ratio of 4.99, compared to 1745971200 on 5266566. Therefore, it implies a Short% of Shares Outstanding of 5278241 and a Short% of Float of 10.07.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
